Oral News and Research

RSS

Oral vaccine prevents prion disease in mice

An oral vaccine can prevent mice from developing a brain disease similar to mad cow disease, according to research presented at the American Academy of Neurology's 59th Annual Meeting in Boston.

4 May 2007

Honey for diabetic ulcers

The sore on Catrina Hurlburt's leg simply wouldn't heal. Complications from a 2002 car accident left Hurlburt, a borderline diabetic, with recurring cellulitis and staph infections.

4 May 2007

Botox decreases pain and intensity of spasticity following a stroke

Final results from a multi-center study shows that repeated treatments of botulinum toxin type A (BoNTA or Botox?) over one year is well tolerated and results in a significant decrease in spasticity, pain frequency and average pain intensity in upper limbs following stroke, according to research from a neurologist at Wake Forest University Baptist Medical Center.

4 May 2007

Study shows effectiveness of Peramivir in mouse model of H5N1 virus infection

BioCryst Pharmaceuticals has announced that investigators at St. Jude Children's Research Hospital, Memphis, TN, reported favorable results evaluating peramivir treatment in an animal model of influenza using a highly virulent strain of H5N1 virus (an avian influenza strain that had caused fatal human infection in Viet Nam).

4 May 2007

FDA approves new indication for FRAGMIN for the extended treatment of symptomatic venous thromboembolism

The U.S. Food and Drug Administration (FDA) has approved a new indication for FRAGMIN (dalteparin sodium injection), for the extended treatment of symptomatic venous thromboembolism (VTE) to reduce the recurrence of VTE in patients with cancer.

4 May 2007

Novel respiratory antibiotic Cethromycin, shown to be effective against Anthrax

Advanced Life Sciences Holdings has announced that its novel respiratory antibiotic, Cethromycin, was shown to be effective in preventing inhalation anthrax infection.

4 May 2007

BioMarin starts phase 2a study of 6R-BH4 in sickle cell disease

BioMarin Pharmaceutical has announced that the first patient has initiated treatment in the Phase 2a clinical study of 6R-BH4 (sapropterin dihydrochloride) for the treatment of sickle cell disease (SCD).

4 May 2007

Reclast found to cause abnormal heart rhythms

An osteoporosis drug with the potential to cut the risk of spine fractures by 70 percent and the chance of hip fractures by 41 percent, has been found to have an adverse side effect on some women.

3 May 2007

Peramivir shows promise for H5N1 protection

The antiviral drug peramivir might offer humans significant protection during a pandemic of the avian influenza virus H5N1, according to results of mouse studies conducted by investigators at St. Jude Children's Research Hospital.

2 May 2007

Afghan President Hamid Karzai meets WHO chief on polio eradication

Days after Afghanistan vaccinated more than 7 million children against polio, the world's top health official and Afghan President Hamid Karzai pledged to capitalize swiftly on the country's remarkable progress towards eradicating the disease.

2 May 2007

Early dental visits decrease kid's tooth decay

The American Academy of Pediatric Dentistry (AAPD), the recognized leader in children's oral health, continues to emphasize that the way to decrease children's tooth decay is by visiting a dentist early on.

2 May 2007

U.S. Supreme Court hears oral arguments in case over Wisconsin antiabortion group's appeal of campaign finance law

The U.S. Supreme Court on Wednesday heard oral arguments in a challenge of a lower court ruling in favor of a Wisconsin anti-abortion group's constitutional challenge to the McCain-Feingold federal campaign finance law, the New York Times reports (Greenhouse, New York Times, 4/26).

30 Apr 2007

Identifying cardiorespiratory neurocircuitry involved in central command during exercise in humans

For almost one hundred years the brain's ,central command, system , whose charge includes controlling the body's cardiorespiratory response to exercise , has been pursued. Animal experiments and functional imaging studies have provided clues to the location of this system, but the underlying electrophysiological activity has never been measured.

30 Apr 2007

Schering-Plough announces European approval of new formulations of AERIUS (Desloratadine)

European Commission approves AERIUS Tablets (2.5 mg and 5 mg) and AERIUS Oral Solution (0.5 mg per 1ml).

30 Apr 2007

Many NYC pharmacies fail to cater for people with poor English

Despite widespread capacity to provide prescription medication labels in languages other than English, few New York City pharmacies do so and as a result, limited-English patients face serious risk of medication error, according to a study by The New York Academy of Medicine presented at the annual meeting of the Society for General Internal Medicine (SGIM) in Toronto, Ontario.

30 Apr 2007